RELMADA THERAPEUTICS, INC.·4

Nov 6, 7:30 AM ET

TRAVERSA SERGIO 4

4 · RELMADA THERAPEUTICS, INC. · Filed Nov 6, 2025

Insider Transaction Report

Form 4
Period: 2025-11-05
TRAVERSA SERGIO
DirectorChief Executive Officer
Transactions
  • Purchase

    Common Stock

    2025-11-05$2.20/sh+272,500$599,5001,272,500 total

Documents

1 file
  • 4
    ownership.xmlPrimary